CS Bio Co: NervGen Pharma Completes Share Issuance to Drug Manufacturing Partner CSBio
Vancouver, British Columbia--(Newsfile Corp. - November 21, 2019) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a regenerative medicine company dedicated to creat...
Read full article »
CS Bio is a California-based company that manufactures and supplies products such as peptides and DNA synthesizers for the pharmaceutical industry.
Read more